Evidence map›Paper›PMID 28836045›Full record

ArticleJournal of medical systems2017

Extreme Learning Machine Framework for Risk Stratification of Fatty Liver Disease Using Ultrasound Tissue Characterization.

Venkatanareshbabu Kuppili, Mainak Biswas, Aswini Sreekumar, Harman S Suri, Luca Saba, Damodar Reddy Edla, Rui Tato Marinho, J Miguel Sanches, Jasjit S Suri

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 4 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Venkatanareshbabu KuppiliDepartment of Computer Science and Engineering, National Institute of Technology Goa, Farmagudi, India.
Mainak BiswasDepartment of Computer Science and Engineering, National Institute of Technology Goa, Farmagudi, India.
Aswini SreekumarDepartment of Computer Science and Engineering, National Institute of Technology Goa, Farmagudi, India.
Harman S SuriGlobal Biomedical Technologies, Inc., Roseville, CA, USA.
Luca SabaDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), Cagliari, Italy.
Damodar Reddy EdlaDepartment of Computer Science and Engineering, National Institute of Technology Goa, Farmagudi, India.
Rui Tato MarinhoLiver Unit, Department of Gastroenterology and Hepatology, Hospital de Santa Maria, Medical School of Lisbon, 1629-049, Lisbon, Portugal.
J Miguel SanchesBioengineering Department, Instituto Superior Tecnico (IST), University of Lisbon, Lisbon, Portugal.
Jasjit S SuriGlobal Biomedical Technologies, Inc., Roseville, CA, USA. jsuri@comcast.net.
National Institute of Technology Goa · INAzienda Ospedaliero-Universitaria Cagliari · ITBrown University · USHospital de Santa Maria · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty Liver Disease (FLD) is caused by the deposition of fat in liver cells and leads to deadly diseases such as liver cancer. Several FLD detection and characterization systems using machine learning (ML) based on Support Vector Machines (SVM) have been applied. These ML systems utilize large number of ultrasonic grayscale features, pooling strategy for selecting the best features and several combinations of training/testing. As result, they are computationally intensive, slow and do not guarantee high performance due to mismatch between grayscale features and classifier type. This study proposes a reliable and fast Extreme Learning Machine (ELM)-based tissue characterization system (a class of Symtosis) for risk stratification of ultrasound liver images. ELM is used to train single layer feed forward neural network (SLFFNN). The input-to-hidden layer weights are randomly generated reducing computational cost. The only weights to be trained are hidden-to-output layer which is done in a single pass (without any iteration) making ELM faster than conventional ML methods. Adapting four types of K-fold cross-validation (K = 2, 3, 5 and 10) protocols on three kinds of data sizes: S0-original, S4-four splits, S8-sixty four splits (a total of 12 cases) and 46 types of grayscale features, we stratify the FLD US images using ELM and benchmark against SVM. Using the US liver database of 63 patients (27 normal/36 abnormal), our results demonstrate superior performance of ELM compared to SVM, for all cross-validation protocols (K2, K3, K5 and K10) and all types of US data sets (S0, S4, and S8) in terms of sensitivity, specificity, accuracy and area under the curve (AUC). Using the K10 cross-validation protocol on S8 data set, ELM showed an accuracy of 96.75% compared to 89.01% for SVM, and correspondingly, the AUC: 0.97 and 0.91, respectively. Further experiments also showed the mean reliability of 99% for ELM classifier, along with the mean speed improvement of 40% using ELM against SVM. We validated the symtosis system using two class biometric facial public data demonstrating an accuracy of 100%.

Indexed as

Liver DiseasesAlgorithmsHumansNeural Networks, ComputerReproducibility of ResultsSupport Vector MachineExtreme learning machineFatty liver diseaseGrayscale featuresNeural networkPerformanceReliabilitySupport vector machine

Identifiers

PMID28836045
OpenAlexW2745765293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.